Skip to main content
SpringerLink
Log in

Bactericidal/permeability increasing protein gene polymorphism and inflammatory bowel diseases: meta-analysis of five case–control studies

  • Rapid Communication
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

Abstract

Objective

Bactericidal/permeability increasing protein (BPI) gene polymorphisms have been extensively investigated in terms of their associations with inflammatory bowel disease (IBD), with contradictory results. The aim of this meta-analysis was to evaluate associations between BPI gene polymorphisms and the risk of IBD, Crohn’s disease (CD), and ulcerative colitis (UC).

Methods

Eligible studies from PubMed, Embase, and Cochrane library databases were identified.

Results

Ten studies (five CD and five UC) published in five papers were included in this meta-analysis. G645A polymorphism was associated with a decreased risk of UC in allele model, dominant model, and homozygous model.

Conclusions

Our data suggested that BPI G645A polymorphism was associated with a decreased risk of UC; the BPI G645A polymorphism was not associated with the risk of CD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Hendrickson BA, Gokhale R, Cho JH (2002) Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev 15(1):79–94

    Article  PubMed  PubMed Central  Google Scholar 

  2. Schultz H, Weiss JP (2007) The bactericidal/permeability-increasing protein (BPI) in infection and inflammatory disease. Clin Chim Acta 384(1–2):12–23

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Torok HP, Glas J, Tonenchi L, Mussack T, Folwaczny C (2004) Polymorphisms of the lipopolysaccharide-signaling complex in inflammatory bowel disease: association of a mutation in the toll-like receptor 4 gene with ulcerative colitis. Clin Immunol 112(1):85–91

    Article  CAS  PubMed  Google Scholar 

  4. Akin H, Tahan G, Ture F, Eren F, Atug O, Tahan V, Hamzaoglu I, Imeryuz N, Tozun N, Hamzaoglu HO (2011) Association between bactericidal/permeability increasing protein (BPI) gene polymorphism (Lys216Glu) and inflammatory bowel disease. J Crohns Colitis 5(1):14–18

    Article  PubMed  Google Scholar 

  5. Can G, Akin H, Ozdemir FT, Can H, Yilmaz B, Eren F, Atug O, Unsal B, Hamzaoglu HO (2015) Bactericidal permeability increasing protein gene polymorphism is associated with inflammatory bowel diseases in the Turkish population. Saudi J Gastroenterol 21(4):239–244

    Article  PubMed  PubMed Central  Google Scholar 

  6. Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25(9):603–605

    Article  PubMed  Google Scholar 

  7. Ownby RL, Crocco E, Acevedo A, John V, Loewenstein D (2006) Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry 63(5):530–538

    Article  PubMed  PubMed Central  Google Scholar 

  8. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558

    Article  PubMed  Google Scholar 

  9. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L (2006) Comparison of two methods to detect publication bias in meta-analysis. JAMA 295(6):676–680

    Article  CAS  PubMed  Google Scholar 

  10. Petermann I, Huebner C, Browning BL, Gearry RB, Barclay ML, Kennedy M, Roberts R, Shelling AN, Philpott M, Han DY, Ferguson LR (2009) Interactions among genes influencing bacterial recognition increase IBD risk in a population-based New Zealand cohort. Hum Immunol 70(6):440–446

    Article  CAS  PubMed  Google Scholar 

  11. Walmsley RS, Zhao MH, Hamilton MI, Brownlee A, Chapman P, Pounder RE, Wakefield AJ, Lockwood CM (1997) Antineutrophil cytoplasm autoantibodies against bactericidal/permeability-increasing protein in inflammatory bowel disease. Gut 40(1):105–109

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

The authors thank all the participants in this study.

Author information

Authors and Affiliations

  1. Department of Gastroenterology, Jining First People’s Hospital, No. 6 health Road, Jining, Shandong Province, 272000, China

    Lijuan Fan, Guoning Fu, Yuanyuan Ding, Peng Lv & Hongyun Li

Authors
  1. Lijuan Fan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Guoning Fu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yuanyuan Ding
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Peng Lv
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hongyun Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hongyun Li.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Lijuan Fan, Guoning Fu, and Yuanyuan Ding have contributed equally to this study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fan, L., Fu, G., Ding, Y. et al. Bactericidal/permeability increasing protein gene polymorphism and inflammatory bowel diseases: meta-analysis of five case–control studies. Int J Colorectal Dis 32, 433–435 (2017). https://doi.org/10.1007/s00384-016-2740-1

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00384-016-2740-1

Keywords

Search

Navigation